CN1590538A - Separation and culturing method of human epidermis stem cell - Google Patents
Separation and culturing method of human epidermis stem cell Download PDFInfo
- Publication number
- CN1590538A CN1590538A CN 03134538 CN03134538A CN1590538A CN 1590538 A CN1590538 A CN 1590538A CN 03134538 CN03134538 CN 03134538 CN 03134538 A CN03134538 A CN 03134538A CN 1590538 A CN1590538 A CN 1590538A
- Authority
- CN
- China
- Prior art keywords
- cell
- stem cells
- epidermal stem
- epidermal
- trophocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A process for separating and culturing human epidermal stem cells includes such steps as providing ectocytic matrix covering Petri dish, separating epidermal cells, preparing trophoblastic cells and screening and culturing epidermal stem cells.
Description
Technical field
The invention belongs to the biomass cells technical field, relate to a kind of separation and extracorporeal culturing method of human epidermal stem cell.
Background technology
Stem cell is the initiating cell that a class has self and differentiation potential, can be divided into embryonic stem cell and adult stem cell.Stem cell has self and unlimited multiplication capacity, can produce well differentiated functioning cell.Because the characteristic of stem cell for the mankind are preparing autogenous cell, tissue, organ, and provides a kind of new thinking in the field of difficult miscellaneous diseases such as treatment cancer, natural immunity disease.At present the research of stem cell mainly concentrates in the world: Embryonic Stem Cell Line system and to the mechanism of mature tissue's cell induction; The horizontal induced differentiation of adult stem cell; The various foundation that are organized into the soma cell bank; The research of the clinical trial of stem cell and the immunological rejection of Transplanted cells.
Studies show that recently ubiquity special adult stem cell in adult tissue and organ, problem is how to seek and separate each specific specificity adult stem cell.And adult stem cell often is arranged in specific microenvironment, has a series of somatomedin or part in this environment, and stem cell and adjacent cells are interacted, renewal and the differentiation of control stem cell.
Epidermal stem cells is present in the stratum basale of skin and mucous membrane, plays an important role in keeping skin and mucous membrane healthy tissues structure and cell homeostasis.At present, gene therapy becomes focus, in the treatment of genodermatosis, reach the gene therapy purpose, must import goal gene in the epidermal stem cells, could obtain the product of this gene in patient's whole machine body skin.Along with the development of developmental biology, find that epidermal stem cells also has important role aspect the reconstruction of damaged skin and mucosal function and structure in addition.
Studies show that epidermal stem cells still exists in vitro culture, and character and similar in vivo the time.Though epidermal stem cells does not have specificity sign molecule at present, relative specificity express keratin 19 and high expression level β 1 integrate plain.Such cell is faster than other cell type in the epidermis to the adhesion speed of IV Collagen Type VI, fiber adhesion element and extracellular matrix, discriminating to epidermal stem cells now utilizes β 1 to integrate plain high level expression more, and the characteristics of the quick adhesion characteristics of pair cell epimatrix are carried out.Graziella P etc. utilizes Fibrinogen and zymoplasm as substrate separation of human epidermal stem cells (J Transplan, 1999,68 (6): 1-12), Jone PH etc. utilizes aforesaid method from people's foreskin (Cell, 1993,73:713-724) or cadaver skin (Cell, 1995,80:83-93) in, utilize the IV Collagen Type VI to do substrate and separate epidermal stem cells, selected substrate costs an arm and a leg, and is not suitable for extensive or long-term cultivation; (JImmunol Methods such as Van Rossum MM, 2002,267:109-17) from people's fritter biopsy, obtain epithelial cells (also claiming epidermic cell), utilize flow cytometer to separate, selecting method complexity and technical requirements height are not easy to promote, and all use the 3T3 cell of mouse as trophoderm in cultivating, because two kinds of cell different generas, can not the residing microenvironment of fine underwriter's epidermal stem cells, and might increase exogenous Hazard Factor for later application.In addition, aspect the epidermal stem cells of long-term cultivation mouse, people (JInvest Dermatol such as Hagar B, 1999,112:971-976) and people (Exp Dermatol such as Dunnwald M, 2001,10:45-54) utilize 50%DMEM, 50% low calcium ion mouse fibroblast cell conditioned medium as substratum, without the trophocyte.But discover if epidermal stem cells and basilar membrane break away from, then can enter the differentiation cycle, be divided into transitional expansion cell, thereby might be one of primary condition of keeping the epidermal stem cells characteristic the high-adhesiveness of basilar membrane.If, might be able to not guarantee the stem cell characteristic of long-term cultivation process mesocuticle stem cell so do not utilize trophoderm.Up to now, the rarely seen at home and abroad report of the human epidermal stem cell of external long-term cultivation.And the epidermal stem cells biology performance, can accomplish to promote function, avoid potential deleterious gene and the different differentiation directions of epidermal stem cells are selected that important directive significance is all being arranged aspect the structure of gene therapy and damage mucous membrane and skin repair, organization engineering skin etc.
Summary of the invention
At the current situation of the technology of the present invention, the purpose of this invention is to provide the method for a kind of human epidermal stem cell separation and vitro culture, and make the epidermal stem cells of acquisition overcome above defective.
The inventive method includes the preparation that extracellular matrix covers plate, the separation of epidermic cell, trophocyte's preparation, the screening of epidermal stem cells and cultivation; Required epidermic cell and the skin that all derives from same individuality as trophocyte's inoblast in above-mentioned extracellular matrix, the epidermal stem cells; Epidermic cell is that gained skin is obtained with enzymic digestion and mechanical separation method.Detailed process is: skin histology is cleaned with the phosphate buffered saline buffer that contains antibiotic; Put in the liquid of protease and digest; Peel off epidermis and skin corium; Collect the epidermis skin graft, put in 0.25% pancreatin/0.02%EDTA (1: 1) mixed solution and digest, stop digestion after, piping and druming a little, filter the back and collect epidermal cell suspension, a gained epidermic cell part is as the preparation extracellular matrix, and a part is used to screen epidermal stem cells.Fibroblastic obtaining is to collect the corium skin graft simultaneously, places collagenase liquid, is gathered into the fibrocyte suspension after the digestion, is used for trophocyte's cultivation; The invention is characterized in:
1. described extracellular matrix covers plate preliminary concrete steps: the gained epidermic cell is inoculated in the plate, is cultured to and converges, inhale and remove nutrient solution; Add ethylenediamine tetraacetic acid (EDTA) (EDTA) and Tutofusin tris hydrochloric acid (Tris HCL) and Triton (Triton) mixed solution, put 37 ℃ and hatch visible cell cracking to the mirror; With PBS buffer solution for cleaning plate; Bovine serum albumin after the adding sex change was put 37 ℃ of incubator 60-90 minutes, to seal non-specific adhesion; PBS cleans plate, adds serum-free medium, puts in the incubator until application;
2. the concrete steps of described trophocyte's preparation are: the inoblast of getting same individual's skin is cultured to and converges, and adding ametycin to final concentration is 10
-6Mol/L, 37 ℃ of overnight incubation are used 0.25% trysinization, stop digestion, the centrifugal supernatant of abandoning, re-suspended cell, standby;
3. the concrete steps of the screening of described epidermal stem cells and cultivation are: get the ready plate that is coated with extracellular matrix, add the epidermal cell suspension (concentration 0.5～2 * 10 of fresh separated
3/ ml), put 37 ℃ of incubator 10-30 minutes, inhale and abandon liquid, PBS cleans to acellular suspension, and wherein attached cell is an epidermal stem cells; Add trophocyte's (density 0.3～1 * 10
4/ cm
2) and the cultivation of KSC nutrient solution, changed liquid, changed liquid once in later per 3 days in the 2nd day; Cell grows to and converges, with 0.25% pancreatin/0.02%EDTA had digestive transfer culture.Wherein the KSC nutrient solution contains foetal calf serum and Basic Fibroblast Growth Factor.
4. detect the feature of epidermal stem cells: vitro culture is observed cell and is the growth of clone's property, and growth cycle is long, and tangible contact growth-inhibiting is arranged; Flow cytometer detects its cell cycle, and the result shows that most of cell is at G
0/ G
1Phase is in relative static conditions, meets the stem cell characteristic.What need at last to carry out is that immunohistochemical methods detects, its method is: the cell of getting the cell of screening and stable 10,20,60,120 PD of cultivation is done and is got rid of sheet, drip one anti-(Keratin sulfate 19 monoclonal antibodies, β 1 integrate plain monoclonal antibody, Keratin sulfate 10 monoclonal antibodies, anti-waveform silk-protein monoclonal antibody) respectively, the result shows that β 1 integrates plain monoclonal antibody 100% positive, Keratin sulfate 19 monoclonal antibodies are about the 94%-97% positive, Keratin sulfate 10 monoclonal antibodies, anti-waveform silk-protein monoclonal antibody are all negative, present the epidermal stem cells feature.
The necessary composition that KSC nutrient solution described in the aforesaid method is contained has: commercial minimum essential nutrient solution DMEM, commercial nutrient solution Ham ' s F12, foetal calf serum, hydrocortisone, Toxins,exo-, cholera, VITAMIN B4, penicillin or Streptomycin sulphate, Prostatropin.The composition that described KSC nutrient solution can add has: calcium chloride, Transferrins,iron complexes.
Description of drawings
The clone Photomicrograph of Fig. 1 for forming in the human epidermal stem cell vitro culture process of the present invention.
Fig. 2 is human epidermal stem cell flow cytometer detected result figure of the present invention.
The cell clone that accompanying drawing 1 expression human epidermal stem cell of the present invention forms in the vitro culture process, upper right portion is the cell clone that forms among the figure, and visible cell is arranged closely, and the cell cell space is less, is polygon; Be the spindle shape person is the trophocyte and periphery is more sparse.
Accompanying drawing 2 is human epidermal stem cell of the present invention results through the flow cytometer detection, shows that most cell is in G
0/ G
1Phase, the slow periodically characteristics of tool.
Embodiment
Get the peritomize skin of foreskin of postoperative of (people) healthy male, preparation epidermic cell and inoblast.
1. the separation of epidermic cell (epithelial cells): get 1-2cm length, the wide skin in the 2mm left and right sides, clean 3 times with the PBS that contains antibiotic; Put in the liquid of protease, 4 ℃ digested 16 hours; Take out skin, peel off epidermis and skin corium; Collect the epidermis skin graft, put in 0.25% pancreatin/0.02%EDTA (1: 1) mixed solution, 37 ℃ digested 10-15 minute, stopped digestion, blow and beat after-filtration a little, collecting cell suspension, the centrifugal supernatant of abandoning, add fresh medium, re-suspended cell is adjusted cell concn to 1 * 10
3/ ml.
2. trophocyte's preparation: the corium skin graft after collecting above-mentioned epidermis and skin corium and peeling off, place 625U/ml collagenase liquid, be gathered into the fibrocyte suspension after the digestion, inoblast is cultured to sprawls about 80%, adding ametycin to final concentration is 10
-6Mol/L.Hatch taking-up in 12 hours for 37 ℃, with 37 ℃ of digestion of 0.25% pancreatin 3-5 minute, stop digestion, centrifugal 5 minutes (800-1000r/ minute) abandons supernatant, and re-suspended cell is standby.
3. extracellular matrix covers the preparation of plate: in plate above-mentioned epidermic cell (also claiming epithelial cells) is cultured to and converges (about 10-14 days); After epidermic cell converges, inhale and remove nutrient solution, clean with aseptic PBS; Add ethylenediamine tetraacetic acid (EDTA) (10mmol/L) and Tutofusin tris hydrochloric acid (25mmol/L) and Triton (1% (w/v)) mixed solution, hatch (30 minutes) visible cell cracking to the mirror for 37 ℃; Clean with PBS; The bovine serum albumin that adds the 0.5mg/ml sex change is again put 37 ℃ and was hatched 1 hour, to seal non-specific adhesion; PBS cleans, and adds serum-free medium, puts 37 ℃ of incubators to using.
4. the screening of epidermal stem cells and cultivation: get the ready plate that is coated with extracellular matrix, add the 2ml epidermal cell suspension, cultivate for 37 ℃ and took out in 10 minutes, inhale and abandon liquid, PBS cleans to acellular suspension, and attached cell is an epidermal stem cells.Add trophocyte (4 * 10
3/ cm
2), cultivate with the KSC nutrient solution, changed liquid on the 2nd day, liquid was changed once in per 3 days in the back.Wherein the KSC nutrient solution contains 5% foetal calf serum and 1ng/ml Basic Fibroblast Growth Factor.Among the present invention, the cultivation of epidermal stem cells is in different steps, and the content of foetal calf serum can be adjusted in the used KSC nutrient solution, and adds different somatomedins.
5. the cultivation of going down to posterity: above-mentioned epidermal stem cells grows to and converges, and with 0.25% pancreatin/0.02%EDTA (1: 1) mixed solution, 37 ℃ of digestion 3-6 minute stops digestion; The collecting cell suspension is gone into centrifuge tube, and centrifugal 5 minutes, abandon supernatant, add fresh medium, re-suspended cell is with 2 * 10
5The density of/ml is inoculated in to spread in advance and is added with in trophocyte's the culturing bottle, puts 37 ℃, 5%CO
2Cultivate in the incubator.
6. cell detection: immunohistochemical methods detected result: cell get rid of sheet β 1 integrate plain 100% express, Keratin sulfate 19 has 95% to express Keratin sulfate 10, anti-waveform silk-protein feminine gender; Transmission electron microscope results: cultured cells, cell space is less, and karyoplasmic ratio is big, and kernel is obvious, and free ribosome is many, and the organoid developmental immaturity is rare relatively; The flow cytometer detected result shows G
0/ G
1Phase cell proportion is 77.2%.With epidermal stem cells with 1 * 10
7The concentration of/ml is planted in the surface of containing the fibroblastic collagen gel of same individuality, carries out organ culture, and pathology section examination confirms to form holostrome differentiation epidermis.In animal body in the experiment, with 2 * 10
7Cell inoculation is in the subcutaneous 4-8 of nude mice week, and no tumour forms.
Epidermal stem cells of the present invention and preparation method thereof has the following advantages: (1) high specificity, detect by immunohistochemical methods detection, transmission electron microscope observing and flow cytometer, and the result shows that epidermal stem cells purity of the present invention is higher; (2) practicability and effectiveness is utilized same individual epithelial cells cracking, and producing with the fiber adhesion element is that the extracellular matrix of main component screens the method simple economy to epidermal stem cells; Utilize the epidermal stem cells of screening in organ culture, can form sophisticated holostrome differentiation epidermis.In addition, utilize same individual inoblast as trophoderm, secretion somatomedin and intercellular interaction can be created one and more be similar to intravital microenvironment, are applied to clinical heterology Hazard Factor after having avoided simultaneously.
Epidermal stem cells has many-sided application prospect owing to himself characteristic, comprising:
(1), the application during organization engineering skin makes up: skin directly contacts with external environment, it is the barrier of human body, by due to wound, serious burn, the big area scar excision etc. during large defect, cause body and can not keep normal homeostasis, even can cause death, therefore need the early stage flap coverage of its analogue, recover the barrier function of skin.Rise along with organizational engineering, can utilize the epidermic cell of cultivation to carry out from body or allosome skin graft flap coverage, but at present the skin graft of cultivating has consuming time, disadvantages affect clinical applications such as stretching resistance is poor, resistance infection difference and expense height, and, can have influence on the normal function of back skin more and to be subjected to the damage of extraneous factor simultaneously because the epithelial cells multiplication capacity is limited.Produce skin graft if utilize epidermal stem cells to cultivate, epidermal stem cells wherein can still keep the self ability, keeps renewal, and certain differentiation potential (can break up epidermis, hair follicle, the differentiation of sebiferous gland direction to holostrome) is arranged, and helps promoting better reparation.
(2), the application in the trauma repair: because epidermal stem cells has self ability and strong multiplication capacity, also can directly apply to the skin and the oral mucosa surface of a wound, promote the healing reparation of wound; In addition, because corneal cell is to be differentiated by cornea stem cell (belonging to epidermal stem cells), in the form of keeping cornea and function, play an important role, thereby epidermal stem cells also may play a role in the trauma repair of corneal.
(3), aspect gene studies: because the lifelong existence of epidermal stem cells aspect the effect and some dermopathic gene mechanism of research gene, can play an important role.
(4), the treatment of heredopathia: can utilize the gene transfection epidermal stem cells, it is carried out the transformation of gene level, genodermatosis is carried out gene therapy.In addition in the treatment of some whole body heredopathia, also can play a role,, make up the covering treatment that organization engineering skin is applied to diabetic ulcer after the transgenosis such as treatment of diabetes, simultaneously can discharge certain treatment factor, diabetes are played certain therapeutic action.
(5), cytophyletic research: epidermal stem cells at first to transition extendibility cytodifferentiation, is divided into postmitotic cell, terminally differentiated cells then, can be the model that research cell lineage facilitates.
The above results shows that human epidermal stem cell of the present invention has strong multiplication capacity, and can form holostrome differentiation epidermis.Along with further going deep into that epidermal stem cells is familiar with, by continuous exploratory development, its application prospect will be more wide.
Claims (4)
1. the separation of a human epidermal stem cell and extracorporeal culturing method include the preparation that extracellular matrix covers plate, the separation of epidermic cell, trophocyte's preparation, the screening of epidermal stem cells and cultivation.Required epidermic cell and all derive from same individual's skin in described extracellular matrix, the epidermal stem cells as trophocyte's inoblast; Epidermic cell is that gained skin is obtained with enzymic digestion and mechanical separation method, it is characterized in that: described extracellular matrix covers plate preliminary step and is: epidermic cell is inoculated in the plate, be cultured to and converge, change liquid adding edta edta and Tutofusin tris hydrochloric acid and Triton mixed solution and hatch; The bovine serum albumin that changes liquid adding sex change was again hatched 60-90 minute, and it is standby to clean the back; The step of described trophocyte's preparation is: the inoblast of getting same individual's skin is cultured to and converges, and adds ametycin and hatches; The screening of described epidermal stem cells and cultivate concrete steps and be: in the ready plate that is coated with extracellular matrix, add epidermal cell suspension, hatch the back and inhale and abandon liquid, clean with phosphate buffered saline buffer, attached cell is an epidermal stem cells; Cultivate with trophocyte and KSC nutrient solution; With pancreatin/EDTA mixed solution had digestive transfer culture.
2, method according to claim 1 is characterized in that: when described epidermal stem cells was cultivated, the density that adds the trophocyte was 0.3～1 * 10
4/ cm
2
3, people's method according to claim 1 is characterized in that: in the screening process of epidermal stem cells, add epidermal cell suspension cell concn should reach 0.5～2 * 10
3/ ml, and hatched 10-30 minute in 37 ℃.
4, method according to claim 1 is characterized in that: the necessary composition that described KSC nutrient solution is contained has: minimum essential nutrient solution DMEM, commercial nutrient solution Ham ' s F12, foetal calf serum, hydrocortisone, Toxins,exo-, cholera, VITAMIN B4, penicillin or Streptomycin sulphate, Prostatropin; The composition that can add has: calcium chloride, Transferrins,iron complexes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03134538 CN1253558C (en) | 2003-09-02 | 2003-09-02 | Separation and culturing method of human epidermis stem cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03134538 CN1253558C (en) | 2003-09-02 | 2003-09-02 | Separation and culturing method of human epidermis stem cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1590538A true CN1590538A (en) | 2005-03-09 |
| CN1253558C CN1253558C (en) | 2006-04-26 |
Family
ID=34597156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03134538 Expired - Fee Related CN1253558C (en) | 2003-09-02 | 2003-09-02 | Separation and culturing method of human epidermis stem cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1253558C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100465279C (en) * | 2006-03-30 | 2009-03-04 | 中国人民解放军第二军医大学 | Prepn and application of epiderm or hair follicle stem cell from souce of human early embryo |
| CN101760449A (en) * | 2009-10-30 | 2010-06-30 | 中国人民解放军总医院 | Method for inducing and acclimating epidermal stem cells into muscle cells |
| CN1869704B (en) * | 2006-06-14 | 2010-06-30 | 厦门大学 | Method for quickly determining host protein interaction with pathogenic bacteria |
| CN102498205A (en) * | 2009-09-15 | 2012-06-13 | 株式会社资生堂 | Method for isolation of dermal stem cell |
| CN101760448B (en) * | 2009-10-30 | 2013-05-29 | 中国人民解放军总医院 | Method for inducing and acclimating epidermal stem cells into functional cells |
| CN107287150A (en) * | 2017-06-18 | 2017-10-24 | 广东博溪生物科技有限公司 | A kind of construction method of 3D epidermises model |
| CN109355256A (en) * | 2018-11-27 | 2019-02-19 | 上海科医联创生物科技有限公司 | A kind of cultural method of fat stem cell |
| CN111500527A (en) * | 2020-06-30 | 2020-08-07 | 北京昱龙盛世生物科技有限公司 | Separation culture method of epidermal stem cells |
| CN111848744A (en) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
-
2003
- 2003-09-02 CN CN 03134538 patent/CN1253558C/en not_active Expired - Fee Related
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100465279C (en) * | 2006-03-30 | 2009-03-04 | 中国人民解放军第二军医大学 | Prepn and application of epiderm or hair follicle stem cell from souce of human early embryo |
| CN1869704B (en) * | 2006-06-14 | 2010-06-30 | 厦门大学 | Method for quickly determining host protein interaction with pathogenic bacteria |
| CN102498205B (en) * | 2009-09-15 | 2014-06-11 | 株式会社资生堂 | Method for isolation of dermal stem cell |
| CN102498205A (en) * | 2009-09-15 | 2012-06-13 | 株式会社资生堂 | Method for isolation of dermal stem cell |
| CN101760448B (en) * | 2009-10-30 | 2013-05-29 | 中国人民解放军总医院 | Method for inducing and acclimating epidermal stem cells into functional cells |
| CN101760449B (en) * | 2009-10-30 | 2013-05-29 | 中国人民解放军总医院 | Method for inducing and acclimating epidermal stem cells into muscle cells |
| CN101760449A (en) * | 2009-10-30 | 2010-06-30 | 中国人民解放军总医院 | Method for inducing and acclimating epidermal stem cells into muscle cells |
| CN107287150A (en) * | 2017-06-18 | 2017-10-24 | 广东博溪生物科技有限公司 | A kind of construction method of 3D epidermises model |
| CN107287150B (en) * | 2017-06-18 | 2020-08-04 | 广东博溪生物科技有限公司 | Construction method of 3D (three-dimensional) epidermis model |
| CN111848744A (en) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
| CN111875674A (en) * | 2018-09-03 | 2020-11-03 | 洛阳轩智生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
| CN111848744B (en) * | 2018-09-03 | 2021-07-23 | 宁波希诺赛生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
| CN111875674B (en) * | 2018-09-03 | 2021-12-10 | 内蒙古创润生物科技有限公司 | Improved method for differentiation of epidermal stem cells into pancreatic cells |
| CN109355256A (en) * | 2018-11-27 | 2019-02-19 | 上海科医联创生物科技有限公司 | A kind of cultural method of fat stem cell |
| CN111500527A (en) * | 2020-06-30 | 2020-08-07 | 北京昱龙盛世生物科技有限公司 | Separation culture method of epidermal stem cells |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1253558C (en) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103667182B (en) | A kind of mesenchymal stem cells MSCs is in vitro to induction method and the inducing culture of osteoblast differentiation | |
| Ge et al. | Comparison of histological structure and biocompatibility between human acellular dermal matrix (ADM) and porcine ADM | |
| CN101773688B (en) | Preparation method of tissue engineering skin containing appendant organs | |
| JPS6133593B2 (en) | ||
| US20040018149A1 (en) | Three-dimensional skin model | |
| CN104312970A (en) | Preparation method of clinical treatment level epidermal stem cell for cell therapy by applying human extracellular matrix screening and mass culture | |
| CN103585177A (en) | Applications of mesenchymal stem cell and genetically modified mesenchymal stem cell | |
| CN1253558C (en) | Separation and culturing method of human epidermis stem cell | |
| CN105112353A (en) | Mixed cultivation method of keratinocyte and melanocyte and application | |
| JP4859671B2 (en) | Preparation of surrogate connective tissue occupied by fibroblasts | |
| CN102335459A (en) | Hair follicle reconstruction method based on hair follicle stem cells and fibroblast | |
| CN104263698A (en) | Screening and culturing methods for large-scale preparation of human extracellular matrix from fibroblasts for clinical treatment level cellular therapy | |
| CN101045916A (en) | Follicular stem cell originated from human hair and its amplifying prepn process | |
| CN103003415A (en) | Process for the production of patches or dressings of autologous skin through cultivation of autologous keratinocytes and fibroblasts with autologous serum for the generation of skin | |
| CN1528253A (en) | Tissue engineered composite skin and preparing method thereof | |
| CN108187142A (en) | A kind of application of stem cell in biological tissue repairs | |
| CN109112101A (en) | A kind of fibroblast culture medium and its application | |
| CN105238739A (en) | Selective culture method for large-scale preparation of human extracellular matrix through melanocytes for clinic treatment level cell therapy | |
| CN105238740A (en) | In-vitro screening and culturing method for tissue engineering skin seed epidermal keratinocyte high-simulation in-vivo cell extracellular matrix attachment | |
| CN111040984A (en) | Method for forming skin fibroblasts by inducing differentiation of umbilical cord mesenchymal stem cells | |
| CN1587393A (en) | Technology for tooth regeneration using keratin stem cell and dental pulp stem cell | |
| CN113025661A (en) | Construction method of immortalized musk glandular epithelial cells | |
| CN1709522A (en) | Artificial bonegraft and its preparing method | |
| CN102614547B (en) | Method for rapidly constructing multilayer cells | |
| CN1141384C (en) | Human marrow-interstitial stem cell and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHAANXI AIERFU ACTIVTISSUE ENGINEERING CO., LTD. Free format text: FORMER OWNER: STOMATOLOGICAL COLLEGE OF THE 4TH MILITARY SURGEON UNIV., CPLA Effective date: 20131218 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710032 XI'AN, SHAANXI PROVINCE TO: 710075 XI'AN, SHAANXI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131218 Address after: High tech Zone in Shaanxi province Xi'an gazelle road 710075 No. 4 Patentee after: Shaanxi Aierfu ActivTissue Engineering Co., Ltd. Address before: 710032 Shaanxi province Xi'an City Rehabilitation Road No. 7 Patentee before: Stomatological College of the 4th Military Surgeon Univ., CPLA |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060426 Termination date: 20190902 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |